Recombinant Human TREML1/TLT-1 (C-6His)

Artikelnummer: ABI-32-7356-10
Artikelname: Recombinant Human TREML1/TLT-1 (C-6His)
Artikelnummer: ABI-32-7356-10
Hersteller Artikelnummer: 32-7356-10
Alternativnummer: ABI-32-7356-10-10UG
Hersteller: Abeomics
Kategorie: Proteine/Peptide
Source: Human Cells. MW :16.88kD. Recombinant Human TREML1 is produced by our Mammalian expression system and the target gene encoding Gln16-Pro162 is expressed with a 6His tag at the C-terminus. Triggering Receptor Expressed on Myeloid Cells-Like Protein 1 (TREML1) is a single-pass type I membrane protein. TREML1 precursor contains a 15 amino acid signal peptide, a 147 amino acid extracellular domain with an Ig-like V-type (immunoglobulin-like) domain, and 128 amino acid cytoplasmic domain. It can be expressed exclusively in platelets and megakaryocytes (MKs). It is a cell surface receptor that may play a role in the innate and adaptive immune response. TREML1 Sequestered in cytoplasmic vesicles in resting platelets. TREML1 be transported to the cell surface after stimulation by thrombin. Soluble fragments can be released into the serum by proteolysis. The phosphorylated TREML1 can interact with PTPN6 and PTPN11. TREML1 may participate in maintaining vascular hemostasis and regulating coagulation and inflammation at sites of injury.
NCBI: 340205
UniProt: Q86YW5
Antibody Type: Recombinant Antibody
Application Verdünnung: Always centrifuge tubes before opening. Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100 µg/ml. Dissolve the lyophilized protein in ddH2O. Please aliquot the reconstituted solution to minimize freez